|Description||Skin and Hair disorder research|
|Series A, 4/2008 |
|Series B, 8/2008 |
|Venture Round, 6/2010 ||$7.5M|
|Venture Round, 11/2010 ||$135k|
Follica, Inc. is developing novel therapies for conditions and disorders of the hair follicle, the epicenter for the development and replenishment of human hair and skin. Treatments for conditions of the follicle account for a total market exceeding $10 billion annually, despite a lack of truly effective solutions.